% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

jmyzal22 7 posts  |  Last Activity: May 12, 2016 3:07 PM Member since: Mar 19, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • by jmyzal22 May 12, 2016 3:07 PM Flag

    Zacks with a 6.00 PT.

    Data on Remoxy will be presented in about 1 hour and 40 minutes. I believe it's head to head against OxyContin.

    Waiting patiently for dur 928 Nash study as that can really open some doors.

    Sentiment: Strong Buy

  • by jmyzal22 May 5, 2016 8:14 PM Flag

    Very excited about dur-928. another condition to be indicated that they're not ready to discuss. Bio markers if move will send us in the spot light with just a single dose.
    Posimir it is my feeling they want to partner this soon. So the partner gets to have a great marketing advantage. Remoxy pain wants to partner. Data against Purdue next week. My assumption is with a growing field in 505-b2 drugs this will call for OxyContin to come off the market.


    Sentiment: Strong Buy

  • Reply to


    by svksudupa Apr 25, 2016 5:29 PM jmyzal22 Apr 25, 2016 6:29 PM Flag

    Not sure, I believe they announced something similar to this last November.

  • by jmyzal22 Apr 20, 2016 8:51 PM Flag

    Would it be unheard of for Pfizer to partner with Pain's Remoxy again?

  • by jmyzal22 Apr 11, 2016 1:22 AM Flag

    Posimir the market reacted to the news. Seems it determined it was a minor setback. NDA is a slam dunk on Remoxy. DUR-928 speculation could send this up 5-10 fold down the road. Should get positive news on single dose in Nash patients. Wild card ZGNX partnering Relday, I think we'll get Orient Pharma data on ADHD phase 3 trial in September. long strong

    Side note: ELTP=trash

    Sentiment: Strong Buy

  • Reply to

    Posimir is positively killing this stock

    by martinmcflyyy Apr 10, 2016 6:18 PM jmyzal22 Apr 11, 2016 1:02 AM Flag

    ELTP= penny stock pump dump.
    Insiders selling.
    Drug won't be approved
    600,000,000 OS

  • Reply to

    More time and cost for POSIMIR trial.....

    by smart_money3000 Apr 7, 2016 10:04 PM jmyzal22 Apr 8, 2016 1:17 AM Flag

    In the last call they said money is not an issue for the phase 3. We'll get more clarity at the end of the month. There should be a dur-928 trial starting soon and data from the Nash single dose this quarter. It's for safety but if it show efficacy it's a home run one (not expecting it to be). Also the PDUFA for Remoxy will be announced this month according to pain.